(19)
(11) EP 4 770 612 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24761973.7

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 36/752(2006.01)
A61K 36/8962(2006.01)
A61P 17/06(2006.01)
A61K 36/185(2006.01)
A61K 36/77(2006.01)
A61P 17/00(2006.01)
A61P 37/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/185; A61K 36/752; A61K 36/77; A61K 36/8962; A61P 17/00; A61P 17/06; A61P 37/00
 
C-Sets:
  1. A61K 36/185, A61K 2300/00;
  2. A61K 36/752, A61K 2300/00;
  3. A61K 36/77, A61K 2300/00;
  4. A61K 36/8962, A61K 2300/00;

(86) International application number:
PCT/EP2024/074087
(87) International publication number:
WO 2025/045950 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 EP 23194615
31.08.2023 US 202318240531

(71) Applicant: LEGACY HEALTHCARE (SWITZERLAND) SA
1066 Epalinges (CH)

(72) Inventors:
  • HARTI, Saad
    1095 Lutry (CH)
  • VINCENT, Nadine
    92400 Courbevoie (FR)

(74) Representative: KATZAROV S.A. 
Geneva Business Center 12 Avenue des Morgines
1213 Petit-Lancy
1213 Petit-Lancy (CH)

   


(54) LONG TERM TREATMENT OF PSORIASIS